Similar to the DFCI group findings, the Children's Oncology Group reported an inferior disease free survival for those patients with high risk ALL not receiving the prescribed asparaginase doses (HR 1.5; 95% CI 1.2–1.9; p = 0.002) (79). Here, ASPG is linked to acute lymphoblastic leukemia.